217 related articles for article (PubMed ID: 26647925)
21. Detection and differential diagnosis of colon cancer by a cumulative analysis of promoter methylation.
Yang Q; Dong Y; Wu W; Zhu C; Chong H; Lu J; Yu D; Liu L; Lv F; Wang S
Nat Commun; 2012; 3():1206. PubMed ID: 23149750
[TBL] [Abstract][Full Text] [Related]
22. Molecular dissection of premalignant colorectal lesions reveals early onset of the CpG island methylator phenotype.
Yamamoto E; Suzuki H; Yamano HO; Maruyama R; Nojima M; Kamimae S; Sawada T; Ashida M; Yoshikawa K; Kimura T; Takagi R; Harada T; Suzuki R; Sato A; Kai M; Sasaki Y; Tokino T; Sugai T; Imai K; Shinomura Y; Toyota M
Am J Pathol; 2012 Nov; 181(5):1847-61. PubMed ID: 22995252
[TBL] [Abstract][Full Text] [Related]
23. Identification of radiation-induced aberrant hypomethylation in colon cancer.
Bae JH; Kim JG; Heo K; Yang K; Kim TO; Yi JM
BMC Genomics; 2015 Feb; 16(1):56. PubMed ID: 25887185
[TBL] [Abstract][Full Text] [Related]
24. DNA methylation markers in colorectal cancer.
Kim MS; Lee J; Sidransky D
Cancer Metastasis Rev; 2010 Mar; 29(1):181-206. PubMed ID: 20135198
[TBL] [Abstract][Full Text] [Related]
25. The methylator phenotype in microsatellite stable colorectal cancers is characterized by a distinct gene expression profile.
Ferracin M; Gafà R; Miotto E; Veronese A; Pultrone C; Sabbioni S; Lanza G; Negrini M
J Pathol; 2008 Apr; 214(5):594-602. PubMed ID: 18241079
[TBL] [Abstract][Full Text] [Related]
26. Are clinicopathological features of colorectal cancers with methylation in half of CpG island methylator phenotype panel markers different from those of CpG island methylator phenotype-high colorectal cancers?
Bae JM; Rhee YY; Kim KJ; Wen X; Song YS; Cho NY; Kim JH; Kang GH
Hum Pathol; 2016 Jan; 47(1):85-94. PubMed ID: 26520418
[TBL] [Abstract][Full Text] [Related]
27. 18q loss of heterozygosity in microsatellite stable colorectal cancer is correlated with CpG island methylator phenotype-negative (CIMP-0) and inversely with CIMP-low and CIMP-high.
Ogino S; Kawasaki T; Kirkner GJ; Ohnishi M; Fuchs CS
BMC Cancer; 2007 May; 7():72. PubMed ID: 17474983
[TBL] [Abstract][Full Text] [Related]
28. Multiplexed profiling of candidate genes for CpG island methylation status using a flexible PCR/LDR/Universal Array assay.
Cheng YW; Shawber C; Notterman D; Paty P; Barany F
Genome Res; 2006 Feb; 16(2):282-9. PubMed ID: 16369045
[TBL] [Abstract][Full Text] [Related]
29. Hypermethylator phenotype in sporadic colon cancer: study on a population-based series of 582 cases.
Barault L; Charon-Barra C; Jooste V; de la Vega MF; Martin L; Roignot P; Rat P; Bouvier AM; Laurent-Puig P; Faivre J; Chapusot C; Piard F
Cancer Res; 2008 Oct; 68(20):8541-6. PubMed ID: 18922929
[TBL] [Abstract][Full Text] [Related]
30. Diet and lifestyle factor associations with CpG island methylator phenotype and BRAF mutations in colon cancer.
Slattery ML; Curtin K; Sweeney C; Levin TR; Potter J; Wolff RK; Albertsen H; Samowitz WS
Int J Cancer; 2007 Feb; 120(3):656-63. PubMed ID: 17096326
[TBL] [Abstract][Full Text] [Related]
31. Microarray-based analysis of whole-genome DNA methylation profiling in early detection of breast cancer.
Li SY; Wu HC; Mai HF; Zhen JX; Li GS; Chen SJ
J Cell Biochem; 2019 Jan; 120(1):658-670. PubMed ID: 30203578
[TBL] [Abstract][Full Text] [Related]
32. High-throughput methylation profiling by MCA coupled to CpG island microarray.
Estécio MR; Yan PS; Ibrahim AE; Tellez CS; Shen L; Huang TH; Issa JP
Genome Res; 2007 Oct; 17(10):1529-36. PubMed ID: 17785535
[TBL] [Abstract][Full Text] [Related]
33. The CpG island methylator phenotype correlates with long-range epigenetic silencing in colorectal cancer.
Karpinski P; Ramsey D; Grzebieniak Z; Sasiadek MM; Blin N
Mol Cancer Res; 2008 Apr; 6(4):585-91. PubMed ID: 18403637
[TBL] [Abstract][Full Text] [Related]
34. Epigenetic regulation of cancer stem cell genes in triple-negative breast cancer.
Kagara N; Huynh KT; Kuo C; Okano H; Sim MS; Elashoff D; Chong K; Giuliano AE; Hoon DS
Am J Pathol; 2012 Jul; 181(1):257-67. PubMed ID: 22626806
[TBL] [Abstract][Full Text] [Related]
35. CpG island methylator phenotype of myelodysplastic syndrome identified through genome-wide profiling of DNA methylation and gene expression.
Zhao X; Yang F; Li S; Liu M; Ying S; Jia X; Wang X
Br J Haematol; 2014 Jun; 165(5):649-58. PubMed ID: 24601943
[TBL] [Abstract][Full Text] [Related]
36. A DNA methylation-based definition of biologically distinct breast cancer subtypes.
Stefansson OA; Moran S; Gomez A; Sayols S; Arribas-Jorba C; Sandoval J; Hilmarsdottir H; Olafsdottir E; Tryggvadottir L; Jonasson JG; Eyfjord J; Esteller M
Mol Oncol; 2015 Mar; 9(3):555-68. PubMed ID: 25468711
[TBL] [Abstract][Full Text] [Related]
37. DNA methylation profile and expression of surfactant protein A2 gene in lung cancer.
Grageda M; Silveyra P; Thomas NJ; DiAngelo SL; Floros J
Exp Lung Res; 2015 Mar; 41(2):93-102. PubMed ID: 25514367
[TBL] [Abstract][Full Text] [Related]
38. [Screening for differential methylation status by CpG island microarray in the hepatocellular carcinoma cell lines].
Zheng D; Liu BB; Liu YK; Kang XN; Sun L; Guo K; Sun RX; Chen J; Zhao Y
Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):891-6. PubMed ID: 19173987
[TBL] [Abstract][Full Text] [Related]
39. Frequent inactivation of SPARC by promoter hypermethylation in colon cancers.
Yang E; Kang HJ; Koh KH; Rhee H; Kim NK; Kim H
Int J Cancer; 2007 Aug; 121(3):567-75. PubMed ID: 17397030
[TBL] [Abstract][Full Text] [Related]
40. Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing.
Gonzalez-Zulueta M; Bender CM; Yang AS; Nguyen T; Beart RW; Van Tornout JM; Jones PA
Cancer Res; 1995 Oct; 55(20):4531-5. PubMed ID: 7553622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
